Arcutis Biotherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Arcutis Biotherapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ARQT

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. 

CEO
Todd Franklin Watanabe
CEOTodd Franklin Watanabe
Employees
354
Employees354
Headquarters
Westlake Village, California
HeadquartersWestlake Village, California
Founded
2016
Founded2016
Employees
354
Employees354

ARQT Key Statistics

Market cap
2.67B
Market cap2.67B
Price-Earnings ratio
-750.70
Price-Earnings ratio-750.70
Dividend yield
Dividend yield
Average volume
2.58M
Average volume2.58M
High today
$21.84
High today$21.84
Low today
$20.94
Low today$20.94
Open price
$21.13
Open price$21.13
Volume
1.60M
Volume1.60M
52 Week high
$31.77
52 Week high$31.77
52 Week low
$12.72
52 Week low$12.72

Stock Snapshot

The current Arcutis Biotherapeutics(ARQT) stock price is $21.12, with a market capitalization of 2.67B. The stock trades at a price-to-earnings (P/E) ratio of -750.70.

On 2026-05-16, Arcutis Biotherapeutics(ARQT) stock moved within a range of $20.94 to $21.84. With shares now at $21.12, the stock is trading +0.9% above its intraday low and -3.3% below the session's peak.

Trading activity shows a volume of 1.6M, compared to an average daily volume of 2.58M.

The stock's 52-week range extends from a low of $12.72 to a high of $31.77.

The stock's 52-week range extends from a low of $12.72 to a high of $31.77.

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own ARQT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.